TRASCO: Study to Compare Standard Perimetry With the New Scotoma-Oriented Perimetry (SCOPE) Using a New Fast German Adaptive Threshold Estimation (GATE) in Glaucoma Patients
Study Details
Study Description
Brief Summary
The purpose of this study is to compare the two psychophysical perimetric techniques regarding progression of the visual field.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
perimetry, HRT, OCT perimetry, HRT, OCT |
Device: Perimetry
different perimetric devices, different perimetric grids: Octopus: New Scotoma-Oriented Perimetry (SCOPE) Using a New Fast German Adaptive Threshold Estimation (GATE) HFA: 30-2, Sita (Swedish Interactive Thresholding Algorithm) full threshold
Other Names:
Device: Confocal Scanning Laser Tomography
HRT examinations for the clinical evaluation of the optic disc.
Other Names:
Device: Optical Coherence Tomography (OCT)
imaging of the retinal nerve fiber layer
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Comparison of rate of progression [36 month]
Perimetric measures every 3 month over 3 years
Eligibility Criteria
Criteria
Inclusion Criteria:
-
primary open angle glaucoma (POAG)
-
spherical ametropia max. ± 8 dpt
-
cylindrical ametropia max. ± 3 dpt
-
distant visual acuity > 10/20
-
pupil diameter > 3 mm
Exclusion Criteria:
-
diabetic retinopathy
-
asthma
-
history of epilepsy or significant psychiatric disease
-
medications known to effect visual field sensitivity
-
infections (e.g., keratitis, conjunctivitis, uveitis)
-
severe dry eyes
-
miotic drug
-
squint
-
nystagmus
-
albinism
-
any ocular pathology, in either eye, that may interfere with the ability to obtain visual fields
-
keratoconus
-
intraocular surgery (except for uncomplicated cataract surgery) performed < 3 month prior to screening
-
history or signs of any visual pathway affection other than glaucoma
-
history or presence of macular disease and/or macular edema, ocular trauma, medications known to affect visual field sensitivity
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Institute for Ophthalmic Research | Tuebingen | Germany | 72076 |
Sponsors and Collaborators
- University Hospital Tuebingen
- Alcon Research
Investigators
- Principal Investigator: Ulrich Schiefer, Prof. Dr. med., University Hospital Tuebingen
Study Documents (Full-Text)
None provided.More Information
Publications
- SCOPE-G-BETA